Announcement on Signing Consulting Agreement and Related Transaction
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment
Announcement on Signing Consulting Agreement and Related Transaction
Filed with SSE ·
Announcement on Signing Consulting Agreement and Related Transaction
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment
6ix hasn’t read this filing yet.
Earlier from BeOne Medicines
- Announcement on Initial Public Offering of Restricted Shares under Strategic Allotment for Circulation
- Announcement on Adjusting Investment Amount of Raised Funds Invested in Investment Subproject Financed by Raised Funds
- Announcement on Convening 2023 3rd Quarter Performance Meeting
- Announcement on Voluntary Disclosure of National Institute for Health and Care Excellence's Recommendation of Baiyueze (Zanubrutinib Capsules) for Treatment of Adult Patients with Chronic Lymphocytic Leukemia
- Announcement on Voluntary Disclosure of Progress in Obtaining Positive Registration of Baize'an (Tislelizumab Injection) in Europe and America
Later from BeOne Medicines
- Announcement on 2023 Annual Preliminary Earnings Estimate
- Announcement on Progress in Joint Investment with Related Party and Related Transaction
- Announcement on Appointing Member of Advisory Committee on Commercial and Medical Affairs of Board of Directors
- Announcement on Equity Registration Date of 2024 Annual General Meeting
- Announcement on Convening 2023 Annual Performance Meeting
Follow BeOne Medicines into a list and get an email when it puts out news.
Follow BeOne Medicines